Skip to main content

Adapting reinsurance to relieve biotech bottleneck

1 June 2008

A pharmaceutical reinsurance mechanism could help fund high-cost research and minimize the market uncertainty that often impairs drug development efforts, thereby stimulating innovation. How would such a mechanism work? Bruce Pyenson explains the concept.



Read or print the article

About the Author(s)

We’re here to help